Health
Results: 2917-2928 of 8769

Implantica announces publication of the landmark RefluxStop® 5-year clinical study results demonstrating excellent long-term success

BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue

Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1





